Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Postoperative Pain
Interventions
DRUG

Liposomal Bupivacaine

20 mL of Liposomal Bupivacaine (EXPAREL) will be diluted in 80 mL of injectable saline used for hydro-dissection of the vesicovaginal space and along the track of the sling trocars

DRUG

Bupivacaine Hydrochloride and Lidocaine

Bupivacaine Hydrochloride (HCL) and Lidocaine. Fifty mL of 0.05% Marcaine and 30 mL of Lidocaine will be diluted in 100 mL of injectable saline used for hydro-dissection of the vesicovaginal space and along the track of the sling trocars during the placement of a suburethral sling.

PROCEDURE

Suburethral Sling

A retropubic, transobturator or mini-sling will be placed in the usual fashion followed by diagnostic cystoscopy.

Trial Locations (2)

07960

Morrristown Medical Center, Morristown

07901

Overlool Medical Center, Summit

Sponsors
All Listed Sponsors
lead

Atlantic Health System

OTHER